Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Focus Universal (NASDAQ:FCUV) Breaks Out 17%: Why Is It Turning Heads?

● FCUV shares gained roughly 17% amid a wild stretch that at one point saw the stock explode from under $2 toward an intraday peak near $21 before settling far lower.

Vinay Lochav | 26 August 2026

Nexera Technologies (NASDAQ:NEXR) Takes Off 14%: Why Is This Tiny Tech Stock Suddenly Moving?

● NEXR shares surged 13.92% without a clearly verifiable, company-specific catalyst, extending a pattern of thin-liquidity spikes and fades.

Vinay Lochav | 26 August 2026

Cable One (NYSE:CABO) Explodes 15% Higher: Can It Stage a Bigger Comeback?

● CABO shares rose about 15% in a single session, clawing back a portion of losses that had left the stock down roughly 60% year to date.

Vinay Lochav | 26 August 2026

GameSquare Holdings (NASDAQ:GAME) Rips 15% Higher: Why Is It Back on Traders' Screens?

● GAME shares rose about 15% after second-quarterRevenueclimbed 137% year over year to $18.5 million, with record adjusted EBITDA of about $1.0 million.

Vinay Lochav | 26 August 2026

HCW Biologics (NASDAQ:HCWB) Jumps 13%: Is This Biotech Stock Starting a New Run?

● HCWB shares rose 12.55% after the company's second-quarter update on HCW9302, showing all three patients in a second dose cohort achieved at least a 25% reduction in SALT scores for alopecia areata.

Vinay Lochav | 26 August 2026

Picard Medical (NYSE American:PMI) Surges 86%: Is It the Next Breakout Stock to Watch?

● Picard Medical shares surged roughly 86% after second-quarter 2026Revenueof about $2.95 million nearly doubled the consensus estimate near $1.55 million.

Vinay Lochav | 26 August 2026

Apollomics (NASDAQ:APLM) Surges 15%: Can It Keep the Biotech Momentum Alive?

● APLM shares climbed 14.68% in a sharp countertrend bounce after a prolonged decline driven by the company's small scale and dilution risk.

Vinay Lochav | 26 August 2026

Cue Biopharma (NASDAQ:CUE) Soars 15%: Is It Entering a Fresh Biotech Rally?

● CUE shares gained roughly 15%, extending a striking year as the company broadens its pipeline beyond its original oncology roots.

Vinay Lochav | 26 August 2026

InflaRx (NASDAQ:IFRX) Rockets 20%: Is the Biotech Rally Just Beginning?

● IFRX shares rocketed 20% without a clearly identifiable, same-day company-specific catalyst, characteristic of a small-cap biotech with a modest float.

Vinay Lochav | 26 August 2026

Prime Medicine (NASDAQ:PRME) Breaks Out 14%: Is Gene-Editing Optimism Returning?

● PRME shares climbed 14.15% amid a broadly firmer tape for advanced-therapy names, without a single Prime-specific disclosure behind the move.

Vinay Lochav | 26 August 2026
Support

Hi! How can we help you today?

Loading…